510(k) Report

PMA · Approved

Approved

Pipeline Embolization Device

P100018/S052PMAApproved Feb 20, 202692-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · OUT Intracranial Aneurysm Flow Diverter

Approved on Feb 20, 2026 through premarket approval, which rests on the device’s own clinical evidence after a 92-day review.

Decided
Feb 20, 2026
Review
92 days
Class
Class III
Product code
OUT
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

FIG. 1 — Lineage of P100018/S052Source: FDA PMA database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OUT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All OUT devices

OUT Intracranial Aneurysm Flow Diverter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · OUT

10in 2025

2011: 32012: 12013: 42014: 32015: 12016: 12017: 12018: 72019: 52020: 92021: 132022: 72023: 82024: 142025: 102026 (partial year): 6
2007high 14 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OUT

Too few OUT 510(k)s in any year since 2007 to give a median.

Recalls per year · OUT

3so far in 2026, the most since 2007

2015: 12016: 1, 1 Class I2025: 12026 (partial year): 3
2007high 3 (2026) · low 0 (2007)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · OUT

1,625in 2025

2011: 42012: 3352013: 6182014: 4382015: 5622016: 5402017: 4482018: 4252019: 5282020: 8092021: 8502022: 1,1182023: 1,1862024: 1,3262025: 1,625
2007high 1,625 (2025) · low 0 (2007)2025

MAUDE reports naming product code OUT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20113—04
20121—0335
20134—0618
20143—0438
20151—1562
20161—1 (1)540
20171—0448
20187—0425
20195—0528
20209—0809
202113—0850
20227—01,118
20238—01,186
202414—01,326
202510—11,625
20266—3—
Cite this page

510(k) Report. “P100018/S052: Pipeline Embolization Device.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P100018/S052

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026